April 22, 2024

Symposium: Accelerating Translation from Discovery to Application

Symposium: Accelerating Translation from Discovery to Application

Titel: Accelerating Translation from Discovery to Application

Termin: 6. Mai 2026

Zeit: 9-13 Uhr

Ort: NMI, Markwiesenstraße 55, 72770 Reutlingen

Teilnahme kostenlos

Mehr Informationen und Anmeldung hier: https://www.nmi.de/en/events/symposium-of-the-biodevcenter


Symposium of the Biological Development Center

Accelerating Translation from Discovery to Application

The development of innovative biologicals often stalls at the transition from academic discovery to clinical application.

The Biologicals Development Center, established by NMI and WSIC with EFRE support, aims to address this challenge by providing comprehensive infrastructure and expertise for the design, production, functionalization, and evaluation of biologicals across therapeutic, diagnostic, and biofunctional domains.

This workshop offers insights into scientific, technological, and manufacturing challenges that shape the future of biologicals. The program includes contributions from the project’s steering committee and invited industry partners.

In addition, the current status of the Center will be presented demonstrating how shared analytical capabilities and structured developability approaches can accelerate early biologicals development.

Together, we explore how coordinated resources and cross‑sector collaboration can strengthen regional innovation and enable biologicals to reach real‑world application faster.

register now

Our latest News

discover more
More precise therapeutic agents for neuropsychiatry: The NMI is helping to unravel complex receptor mechanisms

More precise therapeutic agents for neuropsychiatry: The NMI is helping to unravel complex receptor mechanisms

How can effective treatments for neuropsychiatric disorders be developed without having to accept unwanted side effects? Researchers at the NMI have made an important contribution to this field. In their recent paper, “NMDA receptor subtype differential affinity as a key enabler for precision neuropsychiatry,” they demonstrate how specifically targeting subunits of the NMDA receptor opens […]

Connecting tissue physical changes to what developing cells become

Connecting tissue physical changes to what developing cells become

Scientists find that close interactions between the mechanical properties of tissues and biochemical signalling between cells drive critical cell fate decisions during zebrafish embryo development Summary Embryonic development is one of the most dynamic biological processes in nature. Cells and tissues organise and reorganise themselves following incredibly precise patterns, while remaining flexible and robust. Scientists […]

Excellent doctoral training enters its second phase: Heidelberg University’s medical faculties are continuing a successful Research Training Group in the field of immunology

Excellent doctoral training enters its second phase: Heidelberg University’s medical faculties are continuing a successful Research Training Group in the field of immunology

Joint press release from the medical faculties of Heidelberg and Mannheim The DFG is providing funding of around €5.8 million to support the continuation of Research Training Group 2727, ‘Checkpoints of Innate Immunity in Cancer and Tissue Damage (InCheck)’, led by the Faculty of Medicine in Mannheim. More information in German below: Wie funktionieren die […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp